Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. (Q44053875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

Frank L Greenway

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

James W Anderson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ken Fujioka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kishore M Gadde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

James McKenney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

633-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

Annual Deaths Attributable to Obesity in the United States

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Safety profile of sustained-release bupropion in depression: results of three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Brain dopamine and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

The role of exercise in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Five-year self-management of weight using meal replacements: comparison with matched controls in rural Wisconsin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Weight control in the physician's office

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Long-term weight control with meal replacements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Successful long-term maintenance of substantial weight loss: one program's experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

The spread of the obesity epidemic in the United States, 1991-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Medical hazards of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Long-term weight-loss maintenance: a meta-analysis of US studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Sibutramine produces dose-related weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Pharmacotherapy for obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Exercise enhances dietary compliance during moderate energy restriction in obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Physical activity and long-term maintenance of weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Clinical evaluation of a minimal intervention meal replacement regimen for weight reduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

Metabolic and weight-loss effects of a long-term dietary intervention in obese patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.86

31 March 2020

Identifiers

DOI

10.1038/OBY.2002.86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12105285%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference